Pharma Journalist -

AstraZeneca and MSD Inc., Kenilworth, N.J., US (MSD: known as Merck & Co., Inc. inside the US and Canada) announced the European Commission has approved Lynparza (olaparib) as a…
Read More...

Sanofi and Alnylam have agreed to conclude the research and option phase of the companies’ 2014 RNAi therapeutics alliance in rare genetic diseases. The material collaboration terms for…
Read More...

Exploring Novel Technologies and Bolstering Lyophilisation Strategies for Freeze Drying Optimisation An understanding of the current freeze drying methods, new technologies,…
Read More...

Developing a Human Factors Validation Plan with Consideration for the Digital Health Marketplace This workshop will provide an overview of human factors validation strategies that…
Read More...

Evotec SE and Indivumed GmbH announced that they have entered into a research collaboration to discover and develop first-in-class therapeutics for the treatment of colorectal cancer…
Read More...

Moleculin Biotech announced it has entered into an agreement with Emory University to conduct a Phase 1 clinical trial of WP1066 in children with recurrent or refractory malignant brain…
Read More...

Catalent Pharma Solutions announced the completion of its new, 30,000-square-foot clinical supply facility in Shanghai, China. The event was marked with an official opening ceremony at…
Read More...

Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, announced a new collaboration with…
Read More...

FUJIFILM Diosynth Biotechnologies (Fujifilm), a leading Contract Development and Manufacturing Organization (CDMO) with experience in the development and manufacture of recombinant…
Read More...

Cryoport, Inc. announced it has been selected by Celularity to utilize its complete range of temperature-controlled solutions. Cryoport is the life sciences industry's foremost…
Read More...